Why GLP-1 medications cause nausea
Nausea is the most commonly reported side effect of GLP-1 medications, affecting approximately 40–50% of patients at some point during treatment. It occurs because GLP-1 receptors are present in the brainstem area that controls nausea and vomiting, and because slowed gastric emptying means food sits in the stomach longer than usual.
Importantly, nausea is typically dose-dependent and transient. It is most pronounced during the first few weeks at each new dose level and usually subsides as the body adapts. For most patients, it does not significantly interfere with daily life and resolves within 4–8 weeks of reaching a stable dose.
Practical strategies to reduce nausea
Several evidence-based strategies can meaningfully reduce nausea during GLP-1 treatment. Eating smaller, more frequent meals reduces the volume of food the stomach must process at once. Avoiding high-fat, spicy, or very sweet foods — which already slow gastric emptying — is particularly helpful in the early weeks.
Eating slowly and stopping before you feel full (the medication will reinforce this) also helps. Some patients find that injecting in the evening means any nausea peaks overnight when they are asleep. If nausea is severe, your doctor may recommend pausing dose escalation or prescribing an antiemetic temporarily.
The Open Vault
The Comfort Menu: non-food tools for difficult days
When nausea or fatigue makes eating feel impossible, the Comfort Menu inside The Open Vault gives you a practical toolkit for emotional regulation and non-food coping strategies — so a rough day does not derail your progress.
Open The Comfort MenuConstipation: causes and solutions
Constipation affects approximately 20–30% of patients on GLP-1 medications. Slowed gut motility — the same mechanism that reduces appetite — also slows bowel transit time. Reduced food intake means less fibre and bulk in the gut, compounding the effect.
Increasing fluid intake (aim for 2–2.5 litres of water daily), maintaining dietary fibre through vegetables, legumes, and whole grains, and gentle physical activity all help. Over-the-counter osmotic laxatives such as macrogol (Movicol) are safe to use alongside GLP-1 medications if dietary measures are insufficient.
Less common side effects to be aware of
A small proportion of patients experience more significant side effects. Severe or persistent abdominal pain — particularly pain that radiates to the back and is accompanied by nausea — should prompt immediate medical attention as it may indicate pancreatitis, a rare but serious complication. Treatment must be stopped if pancreatitis is confirmed.
Gallbladder issues, including gallstones, are more common with rapid weight loss regardless of the method. Symptoms include right upper abdominal pain, especially after fatty meals. A small increase in resting heart rate (typically 2–4 beats per minute) has been observed in trials and is generally clinically insignificant but worth monitoring in patients with pre-existing cardiac conditions.
Clinical Support
Experiencing persistent side effects?
Our doctors are available for clinical review if side effects are affecting your quality of life. Dose adjustments, timing changes, and supportive prescriptions can all be discussed.
Book a Clinical Review
